Journal rankings · indicator year 2021
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2021
Cellular and Molecular Neuroscience journal rankings 2021
33 ranked journals · Subfield in Neuroscience
Cellular and Molecular Neuroscience has 33 ranked journals in 2021. The median journal has an OJR of 1.00, level with the world average of 1.00, down 0.01 on 2020; Q1 starts at OJR 1.27. The top three are Neuropsychopharmacology, Fluids and Barriers of the CNS, and Frontiers in Cellular Neuroscience.
Ranks and citation indicators: 2021. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2018–2020, the window the 2021 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Neuroscience (8)
33 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2020. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2018–2020, the window the 2021 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2018–2020 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2012 to 2021. | Compare |
|---|---|---|---|---|---|---|---|
1NeuropsychopharmacologySpringer Nature · United States | 2.21Q1 | 6.84 0.08 down from 2020 | 893 | 100% | $5,290 | ||
2Fluids and Barriers of the CNSOABioMed Central · United Kingdom | 2.14Q1 | 7.86 0.76 down from 2020 | 138 | 100% | $3,390 | ||
3Frontiers in Cellular NeuroscienceOAFrontiers Media · Switzerland | 1.86Q1 | 6.85 0.51 up from 2020 | 1,530 | 100% | $3,801 | ||
4Brain and Neuroscience AdvancesOASAGE Publishing · United States | 1.56Q1 | 4.72 0.23 down from 2020 | 85 | 100% | $1,438 | ||
5NeuropharmacologyElsevier BV · Netherlands | 1.45Q1 | 4.96 0.05 down from 2020 | 1,197 | 54% | $4,300 | ||
6Frontiers in NeuroanatomyOAFrontiers Media · Switzerland | 1.39Q1 | 4.13 0.44 down from 2020 | 315 | 100% | $3,801 | ||
7Molecular BrainOABioMed Central · United Kingdom | 1.38Q1 | 4.80 0.14 up from 2020 | 358 | 100% | $2,890 | ||
8Frontiers in Synaptic NeuroscienceOAFrontiers Media · Switzerland | 1.37Q1 | 4.14 0.68 down from 2020 | 137 | 100% | $3,801 | ||
9PsychopharmacologySpringer Science+Business Media · Germany | 1.27Q1 | 4.40 0.19 down from 2020 | 875 | 50% | $4,390 | ||
10Neuronal SignalingOAPortland Press · United Kingdom | 1.27Q2 | 4.78 1.78 up from 2020 | 39 | 100% | $2,225 | ||
11Journal of Experimental NeuroscienceOASAGE Publishing · United States | 1.26Q2 | 4.00 0.44 up from 2020 | 57 | — | $1,500 | ||
12Frontiers in Neural CircuitsOAFrontiers Media · Switzerland | 1.24Q2 | 3.95 0.14 down from 2020 | 272 | 100% | $3,801 | ||
13Journal of Neuroscience ResearchWiley · United States | 1.23Q2 | 4.03 0.26 up from 2020 | 492 | 46% | $4,840 | ||
14Addiction BiologyOAWiley · United Kingdom | 1.11Q2 | 3.84 0.12 up from 2020 | 386 | 58% | $3,150 | ||
15Journal of Neurosurgery PediatricsUnited States | 1.02Q2 | 3.13 0.24 up from 2020 | 555 | 43% | — | ||
16The CerebellumSpringer Science+Business Media · United Kingdom | 1.02Q2 | 4.10 0.29 up from 2020 | 296 | 47% | $4,790 | ||
17Pharmacology Biochemistry and BehaviorElsevier BV · United States | 1.00Q2 | 3.42 0.10 down from 2020 | 387 | 43% | $3,650 | ||
18Developmental NeurobiologyWiley · United States | 0.98Q3 | 3.33 0.43 up from 2020 | 172 | 52% | $4,550 | ||
19NeuropeptidesElsevier BV · United Kingdom | 0.95Q3 | 3.03 0.13 down from 2020 | 187 | 21% | $3,530 | ||
20AlcoholElsevier BV · United Kingdom | 0.86Q3 | 2.53 0.12 up from 2020 | 268 | 38% | $3,720 | ||
21Journal of Comparative Physiology ASpringer Science+Business Media · Germany | 0.80Q3 | 2.77 0.70 up from 2020 | 212 | 47% | $3,990 | ||
22Journal of Chemical NeuroanatomyElsevier BV · Netherlands | 0.79Q3 | 2.70 0.05 up from 2020 | 256 | 16% | $3,230 | ||
23The Journal of Comparative NeurologyWiley · United States | 0.78Q3 | 2.65 0.18 down from 2020 | 649 | 52% | $5,450 | ||
24Behavioural PharmacologyLippincott Williams & Wilkins · United Kingdom | 0.72Q3 | 2.26 0.07 down from 2020 | 233 | 37% | — | ||
25Cerebellum & AtaxiasBioMed Central · United Kingdom | 0.69Q3 | 1.85 0.61 down from 2020 | 41 | 100% | $2,090 | ||
26SynapseWiley · United States | 0.67Q4 | 2.10 0.47 down from 2020 | 111 | 17% | $3,570 | ||
27Journal of Huntington s DiseaseIOS Press · Netherlands | 0.63Q4 | 1.99 0.12 down from 2020 | 122 | 66% | $4,150 | ||
28Child s Nervous SystemSpringer Science+Business Media · Germany | 0.54Q4 | 1.68 0.21 up from 2020 | 1,159 | 22% | $4,790 | ||
29Invertebrate NeuroscienceSpringer Science+Business Media · Germany | 0.53Q4 | 1.64 0.08 down from 2020 | 52 | — | $3,860 | ||
30Bioelectronics in MedicineFuture Medicine · United Kingdom | 0.53Q4 | 2.17 0.72 up from 2020 | 37 | — | — | ||
31Journal of NeurogeneticsTaylor & Francis · Switzerland | 0.45Q4 | 1.52 0.47 up from 2020 | 117 | 31% | — | ||
| 0.24Q4 | 0.40 0.10 down from 2020 | 43 | 0% | — | |||
| 0.23Q4 | 1.05 0.47 up from 2020 | 33 | 100% | — |
Subfields of Neuroscience, with Cellular and Molecular Neuroscience highlighted.
- Cognitive Neuroscience270
- Cellular and Molecular Neuroscience33
- Neurology20
- Sensory Systems8
- Endocrine and Autonomic Systems5
- Behavioral Neuroscience4
- Biological Psychiatry4
- Developmental Neuroscience0
Journals
Citations made in 2021. Corpus-wide, 87.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
9 additional Cellular and Molecular Neuroscience journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2018–2020, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2021. Publication window: 2018–2020. How these summaries are calculated
- Ranked journals
- 33
- Window papers (baseline)
- 39,824 -1.8% from indicator year 2018
- Median OJR
- 0.997 -13.0% from indicator year 2018
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2018–2020 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 27 | 27 | 26 | 27 | 27 | 32 | 32 | 32 | 31 | 27 | 30 | 32 | 33 | 32 | 30 | 30 | 32 | 32 | 29 | 32 | 33 | 33 | 33 | 32 | 31 | 30 | |
| Window papers (baseline) | 37,773 | 38,664 | 38,213 | 37,940 | 37,414 | 38,123 | 38,289 | 38,810 | 38,951 | 41,086 | 41,577 | 41,975 | 41,244 | 41,433 | 42,264 | 42,615 | 42,554 | 41,749 | 40,554 | 39,909 | 39,604 | 39,824 | 40,023 | 39,750 | 39,038 | 38,750 | |
| Median OJR | 0.73 | 0.74 | 0.83 | 0.790 | 0.86 | 0.894 | 0.91 | 0.885 | 0.94 | 1.16 | 1.18 | 1.12 | 1.07 | 1.147 | 1.14 | 1.153 | 1.13 | 1.149 | 1.146 | 1.04 | 1.004 | 0.997 | 0.93 | 0.88 | 0.90 | 0.791 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.